cholesteryl myristate
(3beta)-cholest-5-en-3-yl tetradecanoate
Identification
| Name | cholesteryl myristate |
| CAS Number | 1989-52-2 |
| EINECS | 217-867-8 |
| FDA UNII | Search |
| Molecular Formula | C41 H72 O2 |
| Molecular Weight | 597.02324000 |
| MDL Number | MFCD00307644 |
| Nikkaji Number | J151.217J |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 630.67 °C. @ 760.00 mm Hg (est) |
| Flash Point | 635.00 °F. TCC ( 334.80 °C. ) (est) |
| logP (o/w) | 16.656 (est) |
| Soluble in | water, 7.438e-012 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Preferred SDS | View |
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | information only not used for fragrances or flavors |
| Recommendation for cholesteryl myristate usage levels up to | not for fragrance use. |
| Recommendation for cholesteryl myristate flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Potential Uses
Natural Occurrence
Synonyms
(3b)-
cholest-5-en-3-yl myristate
(3beta)-
cholest-5-en-3-yl tetradecanoate
cholest-5-en-3beta-yl myristate
cholesterol 1-tetradecanoate
cholesterol myristate
cholesterol, myristate (8CI)
cholesteryl tetradecanoate
cholestryl myristate
[(3S,8S,9S,10R,13R,14S,17R)-10,13-
dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] tetradecanoate
tetradecanoic acid, (3b)-cholest-5-en-3-yl ester
PubMed:
Chemical stability of phospholipid-stabilized supercooled smectic cholesteryl myristate nanoparticles.
PubMed:
PEGylation of supercooled smectic cholesteryl myristate nanoparticles.
PubMed:
The physical state of lipid nanoparticles influences their effect on in vitro cell viability.
PubMed:
Cholesterol myristate suppresses the apoptosis of mesenchymal stem cells via upregulation of inhibitor of differentiation.
PubMed:
Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles.
PubMed:
The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations.
PubMed:
Autocrine BMP4 signaling involves effect of cholesterol myristate on proliferation of mesenchymal stem cells.
PubMed:
Calculation of the T-X phase diagrams for binary mixtures of cholestanyl myristate-cholesteryl myristate and cholestanyl myristate-cholesteryl oleate.
PubMed:
Effect of lysozyme adsorption on the interfacial rheology of DPPC and cholesteryl myristate films.
PubMed:
[Studies on chemical constituents of marine bryozoan Bugula neritina L].
PubMed:
Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles.
PubMed:
Serum fatty acids as biomarkers of fat intake predict serum cholesterol concentrations in a population-based survey of New Zealand adolescents and adults.
PubMed:
Novel cholesterol esterase secreted by Streptomyces persists during aqueous long-term storage.
PubMed:
Viscosity peaks at the cholesteric-isotropic phase transitions.
PubMed:
Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers.
PubMed:
Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.
PubMed:
Analysis of adrenal cholesteryl esters by reversed phase high performance liquid chromatography.
PubMed:
Molecular organization and motions of cholesteryl esters in crystalline and liquid crystalline phases: a 13C and 1H magic angle spinning NMR study.
PubMed:
Crystal structure of cholestanyl caprylate and binary phase behavior with cholesteryl caprylate.
PubMed:
Cholesteryl esters of saturated fatty acids: cosolubility and fractionation of binary mixtures.
PubMed:
Thermotropic mesomorphism of cholesteryl myristate. An electron diffraction study.
PubMed:
Structure of the cholesteryl ester core of human plasma low density lipoproteins: selective deuteration and neutron small-angle scattering.
PubMed:
Cholesteryl myristate conformation in liquid crystalline mesophases determined by neutron scattering.
PubMed:
Interactions of cholesterol esters with phospholipids: cholesteryl myristate and dimyristoyl lecithin.
PubMed:
Structure of human plasma low-density lipoproteins: molecular organization of the central core.
PubMed:
Thermal stability of biological lipids. I. Differential scanning calorimetry of mixtures of cholesteryl myristate and cholesteryl palmitate.
PubMed:
Light scattering and microscopic investigations of mesophase transitions of cholesteryl myristate. II. Kinetics of spherulite formation.
PubMed:
Light scattering and microscopic investigations of mesophase transition of cholesteryl myristate. I. Morphology of the cholesteric phase.